A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life-Reference-Cited by-同舟云学术

A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life

Published:1996-01 Issue:1 Volume:128 Page:135-137
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Rosenthal Joseph,Healey Timothy,Ellis Robin,Gillan Eileen,Cairo Mitchell S.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference6 articles.

1. A randomized, placebo-controlled trial of recombinant human granulocyte-colony stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia;Gillan;Blood,1994

2. Early intervention developmental profile;Rogers,1981

3. Reference values in infancy and childhood;Lubin,1993

4. American society of clinical oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines;Miller;J Clin Oncol,1994

5. Nonhandicapped very-low-birth-weight infants at one year of age: developmental profile;Williamson;Pediatrics,1990

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors;Biology of Blood and Marrow Transplantation;2018-04

2. Recombinant G-CSF Treatment of Severe Chronic Neutropenia in Neonates and Infants;Neonatology;2018

3. Recombinant G-CSF Treatment of Severe Chronic Neutropenia in Neonates and Infants;Neonatology;2016

4. Granulocyte colony-stimulating factor (G-CSF);Meyler's Side Effects of Drugs;2016

5. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial;Journal of the American Academy of Dermatology;2015-07